Journal
INTERNATIONAL JOURNAL OF DRUG POLICY
Volume 21, Issue 3, Pages 186-193Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.drugpo.2009.01.003
Keywords
Opioid overdose; Naloxone; Evaluation; Injection drug use; Intervention; Homeless
Categories
Funding
- NIDA NIH HHS [R01 DA016310] Funding Source: Medline
Ask authors/readers for more resources
Background: Fatal opioid overdose is a significant cause of mortality among injection drug users (IDUs). Methods: We evaluated an overdose prevention and response training programme for IDUs run by a community-based organisation in Los Angeles, CA. During a 1-h training session participants learned skills to prevent, recognise, and respond to opioid overdoses, including: calling for emergency services, performing rescue breathing, and administering an intramuscular injection of naloxone (an opioid antagonist). Between September 2006 and January 2008, 93 IDUs were trained. Of those, 66 (71%) enrolled in the evaluation study and 47 participants (71%) completed an interview at baseline and 3-month follow-up. Results: Twenty-one percent of participants were female, 42% were white, 29% African American, and 18% Latino. Most were homeless or lived in temporary accommodation (73%). We found significant increases in knowledge about overdose, in particular about the use of naloxone. Twenty-two participants responded to 35 overdoses during the follow-up period. Twenty-six overdose victims recovered, four died, and the outcome of five cases was unknown. Response techniques included: staying with the victim (85%), administering naloxone (80%), providing rescue breathing (66%), and calling emergency services (60%). The average number of appropriate response techniques used by participants increased significantly from baseline to follow-up (p < 0.05). Half (53%) of programme participants reported decreased drug use at follow-up. Conclusion: Overdose prevention and response training programmes may be associated with improved overdose response behaviour, with few adverse consequences and some unforeseen benefits, such as reductions in personal drug use. (C) 2009 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available